Conference Proceedings

Comparison of the efficacy and safety of SPD476, a novel, once-daily, high-dose formulation of mesalamine, and Asacol with placebo for the induction of remission of mild-moderate ulcerative colitis: A phase III study

MA Kamm, WJ Sandborn, M Gassull, S Schreiber, L Jackowski

AMERICAN JOURNAL OF GASTROENTEROLOGY | BLACKWELL PUBLISHING | Published : 2005